Policy & Medicine

Legal, Regulatory, and Compliance Issues

facebook
twitter
google_plus
Email

Browsing daily archive

June 5, 2018

Connecticut’s New Drug Pricing Law Requires Transparency from PBMs, Health Carriers, and Pharmaceutical Manufacturers

Open Payments
Litigation
FDA
CME
Opioids
International
State Policy
Transparency
COVID-19
CMS
MACRA

View Desktop Version